chr6-42828494-A-G
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_001393499.1(BICRAL):āc.161A>Gā(p.Asn54Ser) variant causes a missense, splice region change. The variant allele was found at a frequency of 0.0000212 in 1,604,520 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001393499.1 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
BICRAL | NM_001393499.1 | c.161A>G | p.Asn54Ser | missense_variant, splice_region_variant | 6/13 | ENST00000314073.10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
BICRAL | ENST00000314073.10 | c.161A>G | p.Asn54Ser | missense_variant, splice_region_variant | 6/13 | 1 | NM_001393499.1 | P1 | |
BICRAL | ENST00000394168.1 | c.161A>G | p.Asn54Ser | missense_variant, splice_region_variant | 5/12 | 1 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152096Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000369 AC: 9AN: 244050Hom.: 0 AF XY: 0.0000530 AC XY: 7AN XY: 132076
GnomAD4 exome AF: 0.0000213 AC: 31AN: 1452424Hom.: 0 Cov.: 31 AF XY: 0.0000235 AC XY: 17AN XY: 722440
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152096Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74296
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 12, 2021 | The c.161A>G (p.N54S) alteration is located in exon 5 (coding exon 4) of the GLTSCR1L gene. This alteration results from a A to G substitution at nucleotide position 161, causing the asparagine (N) at amino acid position 54 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at